McAllen Advanced Medical Imaging — McAllen, Texas

McAllen Advanced Medical Imaging is a clinical research site located in McAllen, Texas, United States 78501.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

McAllen Advanced Medical Imaging has participated in 1 clinical trials.

Therapeutic areas: Age-Related Maculopathy.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in McAllen

Browse all research sites in Texas · View every site in McAllen

• Doctors Hospital at Renaissance
• McAllen Medical Heart Hospital
• University of Texas Medical Branch Cancer Stop McAllen Clinic
• Rio Grande Regional Hospital Main Campus
• Rio Grande Regional Hospital
• Doctor's Hospital at Renaissance
• Valley Retina Institute
• Research Site
• Futuro Clinical Trials
• Valley Retina Institute,PA
• Texas Oncology McAllen
• Biopharma Informatic

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for McAllen Advanced Medical Imaging?

McAllen Advanced Medical Imaging has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has McAllen Advanced Medical Imaging conducted?

McAllen Advanced Medical Imaging has 1 clinical trials on record. Their work covers Age-Related Maculopathy.

Is McAllen Advanced Medical Imaging accredited by Crixeo Clinical Trials?

McAllen Advanced Medical Imaging has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about McAllen Advanced Medical Imaging?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.